Abstract
Intramuscular myxoma is a benign neoplasm currently classified among soft tissue tumors of uncertain differentiation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
GNAS: alternative splicing of downstream exons of this gene (also named GNAS complex locus and guanine nucleotide-binding protein alpha-stimulating activity polypeptide 1) results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking G protein-coupled receptors (GPCR) with the activation of adenylyl cyclase and ultimately a variety of cell activities.
Suggested Readings
Allen (2000) Myxoma is not a single entity: a review of the concept of myxoma. Ann Diagn Pathol 4(2):99–123
Delaney (2009) GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol 22(5):718–724
Fletcher (2020) WHO classification of tumours of soft tissue and bone (5th edition)
Vescini (2019) Mazabraud’s syndrome: a case report and up-to-date literature review. Endocr Metab Immune Disord Drug Targets 19(6):885–893
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Intramuscular Myxoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_136
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_136
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)